QUANTUM BIOPHARMA LTD (QNTM) Stock News

NASDAQ:QNTM - CA74764Y2050 - Common Stock

18.16 USD

+0.08 (+0.44%)

Last: 8/25/2025, 10:31:54 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

QNTM Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Quantum BioPharma

Quantum BioPharma Announces Corporate Updates

4 days ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Announces Corporate Updates

14 days ago - By: Benzinga

Why Quantum BioPharma (QNTM) Stock Is Soaring Today

14 days ago - By: Quantum BioPharma

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

14 days ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

17 days ago - By: Quantum BioPharma

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

17 days ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

18 days ago - By: Quantum BioPharma

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of

18 days ago - By: Quantum BioPharma - Mentions: -

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of

20 days ago - By: Benzinga - Mentions: PSIL

Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug

20 days ago - By: Quantum BioPharma

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

20 days ago - By: Quantum BioPharma - Mentions: -

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

21 days ago - By: Quantum BioPharma

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

21 days ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

25 days ago - By: Quantum BioPharma

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

25 days ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

a month ago - By: Quantum BioPharma - Mentions: - GME

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

2 months ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom

2 months ago - By: Quantum BioPharma

Quantum BioPharma Announces Private Placement of 12 Class A Multiple Voting Shares at a Price of $50 Per Share

2 months ago - By: Quantum BioPharma

Quantum BioPharma Announces Private Placement

2 months ago - By: Quantum BioPharma

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

2 months ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

2 months ago - By: Quantum BioPharma

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

2 months ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

2 months ago - By: Quantum BioPharma

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

2 months ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

3 months ago - By: Quantum BioPharma - Mentions: -

Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000

3 months ago - By: Quantum BioPharma

Quantum BioPharma Clarifies It Has Not Changed Its Name

3 months ago - By: Quantum BioPharma - Mentions: -

Quantum BioPharma Clarifies It Has Not Changed Its Name